Blood Bag Manufacturing Business in India

Blood Bag Manufacturing Business in India: CDSCO Class D Licensing, BIS IS:15716, Investment and Market Demand

Blood Bag Manufacturing Business in India: CDSCO Class D Licensing, BIS IS:15716, Investment and Market Demand Read More »

Blood Bag Manufacturing Business in India With less than 15 active manufacturers in India, serving a market of Rs 700-900 crore, every blood bag collected is clinically necessary as there is a shortage of blood units while a non-existent supply chain makes every single blood bag collected indispensable for blood banks across India, with quality manufacturers charging premium prices and secured vendor status. Market Opportunity: Why This Business Cannot Be Ignored Blood bags are added to the highest risk class D medical devices under MDR 2017, as defects may pose a direct threat to patients’ lives during a transfusion. All the class D manufacturers are required to be licensed by central CDSCO in addition to state SLA, have validated ETO processing, have thorough biocompatibility testing as per ISO 10993 and have validated ISO 13485 QMS. The barriers help quality producers to exclude the low-quality producers and make the market very attractive to serious and compliant manufacturers. The National AIDS Control Organisation (NACO), India, oversees more than 3200 blood banks which are licensed and have established certain technical requirements for the blood bags in government blood banking. The approved vendor list is the first step towards national procurement programmes which ensure payment of multi-year supply contracts to technically compliant manufacturers, one of the most predictable, and margin resilient, revenue models within the Indian medical device industry. Get Detailed Insights from This Book: Handbook on Medical and Surgical Disposable Products  Industry Analysis: Growth Drivers and Demand Outlook The blood bag market in India is estimated at Rs. 700-900 crore with 10-12 percent growth year-on-year. The Ministry of Health and Family Welfare has formulated a National Blood Policy that has been implemented in district hospitals under NHM, and which requires hundreds of new blood banks per year, all of which constitute a captive, predictable buyer of blood bags in single, double, triple and quadruple packs. The National AIDS Control Organisation (NACO) Blood bank portal keeps the list of approved vendors, technical specifications, and procurement procedures that blood bag producers need to meet and provide before they can receive contracts for blood bag supply from across 3200+ blood banks across the country. There are very few manufacturers that cater this sector namely BPL Biotech, Span Medical Products, Hi-Tech Medical and international brands. When a new company gets CDSCO Class D approval and NACO vendor list approval, they instantly have access to all the procurement opportunities across the country. Blood bags are identified as a medical devices initiative priority product category by Make in India and available for PLI Medical Devices for Class D approved manufacturers. According to Invest India blood storage systems are one of the high priority local manufacturing segments which can benefit from PLI scheme and also be preferred by the government for procurement as per the blood bag import substitution report, based on government data. India Blood Bag Market Overview Parameter Market Data Source or Notes India Annual Blood Requirement 15+ million units per year Ministry of Health estimates Actual Blood Collection 12-13 million units per year NACO Annual Report Blood Bag Market Value Rs 700 – 900 crore Industry estimates Market Growth Rate 10-12% per year NACO blood bank expansion Number of Licensed Blood Banks 3,200+ across India NACO national survey CDSCO Classification Class D (highest risk category) MDR 2017 India BIS Standard for Blood Bags IS:15716 Mandatory BIS certification How to Start: Step-by-Step Guide for Entrepreneurs Step 1: Technical Feasibility Study and Regulatory Strategy The manufacturing of blood bags is the most technically challenging business in medical devices industry in India. Prior to investment, perform a comprehensive technical feasibility study that includes clean room requirements, ETO sterilisation validation plan, biocompatibility testing, ISO 13485 QMS scope and a CDSCO class D licensing timeline. NPCS can do this feasibility study as the base of your investment decision as well as bank loan application. Blood bag manufacturing units should enrol on the Udyam MSME Registration Portal so that they can avail collateral free loan from CGTMSE, term loan from SIDBI and government subsidy on investment in the huge investment of clean room and ETO sterilisation equipment. Get Detailed Project Report (DPR): Blood Bags Manufacturing Plant Report Step 2: CDSCO Class D Manufacturing Licence Please apply for CDSCO Class D Medical Device Manufacturing Licence in Central office at New Delhi. Requirements are validated ISO Class 7/8 clean rooms, validated ETO sterilisation process with biological indicator monitoring, ISO 13485 QMS certification, biocompatibility data (ISO 10993) and a complete device master record. The whole process of getting CDSCO inspection and approval to get registered as a class D can take 12-18 months, so start preparing early. Step 3: Clean Room, RF Welding, and Sterilisation Infrastructure The required minimum size for a blood bag plant is 6,000-10,000 sq ft, and includes critical assembly (RF or HF dielectric welding machines for sealing PVC bag bodies) and secondary assembly (tube assembly, needle stations, anti-coagulant pre-fill stations) equipment, as well as validated ETO sterilisation chambers. Step 4: Anticoagulant Formulation and Fill Blood bags are provided pre-filled with anticoagulant-preservative solutions: CPDA-1 (blood shelf life of 35 days, most commonly used in India), CPD (blood shelf life of 21 days) or SAG-M (Additive solution bag with blood shelf life of 65 days for the storage of red cells). The formulation needs to be validated for fill accuracy and to be sterile and pharmaceutical grade mixed and filled. The CPD, CPDA-1 and SAG-M blood storage systems are as per the WHO guidelines for Blood Transfusion services and are matched to the BIS IS:15716 compliance of blood bags in India. Step 5: BIS Certification, NACO Approval, and Sales Get BIS IS:15716 certification and join the list of approved Vendors of NACO for Government blood bank procurement. At the same time develop private blood bank connections at corporate hospitals like Apollo, Fortis, Medinat, Max etc., where the premium pricing allows a much larger margin over the government tenders. Find high-return business ideas based on your budget & ROI Project Investment Breakdown for Blood